ABSTRACT
AIM: The gut-liver axis may contribute to pathophysiology of cholestatic liver disorders like biliary atresia (BA) by bacterial translocation (BT). Toll-like receptors (TLR) are pattern recognition receptors known to activate innate immunity and secretion of inflammatory cytokines. Herein, we examined BT-associated biomarkers and TLRs in relation to liver injury after successful portoenterostomy (SPE) in BA. METHODS: Serum levels of lipopolysaccharide-binding protein (LBP), CD14, LAL, TNF-α, IL-6 and FABP2 along with liver expression of TLRs (TLR1, TLR4, TLR7 and TLR9), LBP and CD14 were measured during median 4.9 (1.7-10.6) years follow-up after SPE in 45 BA patients. RESULTS: Serum LBP, CD14, TNF-α and IL-6 all increased after SPE whereas LAL and FABP-2 remained unchanged. Serum LBP correlated positively with CD14 and markers of hepatocyte injury and cholestasis, but not with Metavir fibrosis stage, transcriptional markers for fibrosis (ACTA2) or ductular reaction. Serum CD14 concentration was significantly higher in patients with portal hypertension than without. While liver expression of TLR4 and LBP remained low, TLR7 and TLR1 showed marked BA-specific increases, and TLR7 correlated with Metavir fibrosis stage and ACTA2. CONCLUSION: BT does not seem to play a significant role in liver injury after SPE in our series of BA patients.
Subject(s)
Bacterial Translocation , Biliary Atresia , Portoenterostomy, Hepatic , Toll-Like Receptors , Child , Humans , Biliary Atresia/surgery , Portoenterostomy, Hepatic/methods , Toll-Like Receptors/blood , Biomarkers , Tumor Necrosis Factor-alphaABSTRACT
Acetylsalicylic acid is a globally used non-steroidal anti-inflammatory drug (NSAID) with diverse pharmacological properties, although its mechanism of immune regulation during inflammation (especially at in vivo relevant doses) remains largely speculative. Given the increase in clinical perspective of Acetylsalicylic acid in various diseases and cancer prevention, this study aimed to investigate the immunomodulatory role of physiological Acetylsalicylic acid concentrations (0.005, 0.02 and 0.2 mg/ml) in a human whole blood of infection-induced inflammation. We describe a simple, highly reliable whole blood assay using an array of toll-like receptor (TLR) ligands 1-9 in order to systematically explore the immunomodulatory activity of Acetylsalicylic acid plasma concentrations in physiologically relevant conditions. Release of inflammatory cytokines and production of prostaglandin E2 (PGE2) were determined directly in plasma supernatant. Experiments demonstrate for the first time that plasma concentrations of Acetylsalicylic acid significantly increased TLR ligand-triggered IL-1ß, IL-10, and IL-6 production in a dose-dependent manner. In contrast, indomethacin did not exhibit this capacity, whereas cyclooxygenase (COX)-2 selective NSAID, celecoxib, induced a similar pattern like Acetylsalicylic acid, suggesting a possible relevance of COX-2. Accordingly, we found that exogenous addition of COX downstream product, PGE2, attenuates the TLR ligand-mediated cytokine secretion by augmenting production of anti-inflammatory cytokines and inhibiting release of pro-inflammatory cytokines. Low PGE2 levels were at least involved in the enhanced IL-1ß production by Acetylsalicylic acid.
Subject(s)
Aspirin/pharmacology , Cytokines/genetics , Inflammation/drug therapy , Toll-Like Receptors/genetics , Adjuvants, Immunologic/pharmacology , Adolescent , Adult , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Celecoxib/pharmacology , Cyclooxygenase 2/blood , Cyclooxygenase 2/genetics , Cytokines/biosynthesis , Dinoprostone/genetics , Gene Expression Regulation/drug effects , Humans , Indomethacin/pharmacology , Inflammation/blood , Inflammation/pathology , Interleukin-10/genetics , Interleukin-1beta/genetics , Interleukin-6/genetics , Leukocytes/drug effects , Male , Middle Aged , Toll-Like Receptors/blood , Young AdultABSTRACT
Diabetic neuropathy is one of the most common complications of diabetes. This complication is peripheral neuropathy with predominant sensory impairment, and its symptoms begin with hyperesthesia and pain and gradually become hypoesthesia with the loss of nerve fibers. In some cases, lower limb amputation occurs when hypoalgesia makes it impossible to be aware of trauma or mechanical stimuli. On the other hand, up to 50% of these complications are asymptomatic and tend to delay early detection. Therefore, sensitive and reliable biomarkers for diabetic neuropathy are needed for an early diagnosis of this condition. This review focuses on systemic biomarkers that may be useful at this time. It also describes research on the relationship between target gene polymorphisms and pathological conditions. Finally, we also introduce current information on regenerative therapy, which is expected to be a therapeutic approach when the pathological condition has progressed and nerve degeneration has been completed.
Subject(s)
Cytokines/therapeutic use , Diabetic Neuropathies/therapy , Neurons/drug effects , Regenerative Medicine/methods , Animals , Biomarkers/blood , Cytokines/pharmacology , Diabetic Neuropathies/drug therapy , Diabetic Neuropathies/genetics , Diabetic Neuropathies/physiopathology , Exosomes/metabolism , Glyoxal/blood , Humans , Inflammation/immunology , Inflammation/metabolism , Lactoylglutathione Lyase/blood , MicroRNAs/genetics , MicroRNAs/metabolism , Nerve Fibers/drug effects , Nerve Fibers/pathology , Neurons/metabolism , Polymorphism, Genetic , Pyruvaldehyde/blood , Toll-Like Receptors/blood , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolismABSTRACT
BACKGROUND: Nasopharyngeal carcinoma (NPC) originates in the nasopharyngeal epithelium. The most common treatments for NPC rT1-4 are radiotherapy and surgery. The pathogenesis of radiation-induced cognitive impairment is complex and includes oxidative stress, mitochondrial dysfunction, neuro-inflammation, and even apoptosis and cell death. Principally, toll-like receptors (TLRs) could regulate the inflammatory/anti-inflammatory balance in patients with radiation-induced brain injury. Vinpocetine has an anti-inflammatory effect as shown in both animal and in vitro studies. Also, dexamethasone is a widely used anti-inflammatory drug. Thus, it is important to test whether addition of vinpocetine could improve the anti-inflammatory properties of dexamethasone for the treatment of NPC patients with radiation-induced brain injuries. METHODS: A total of 60 NPC patients with radiation-related brain injury were recruited for this study. All subjects were randomly and blindly assigned to the following groups: the dexamethasone group (D group, n = 30) and the vinpocetine and dexamethasone group (VD group, n = 30). Both medicine treatments were uninterrupted for 14 days of administration. RESULTS: Combined administration of vinpocetine and dexamethasone lowered the expression levels of serum inflammatory cytokines, including TLR2, TLR4, interleukin (IL)-20, IL-8, tumor necrosis factor-α, interferon-γ, monocyte chemoattractant protein 2, and interferon-induced protein 20, when compared to dexamethasone monotherapy. Notably, combination therapy increased antioxidants (superoxide dismutase, glutathione, glutathione peroxidase, and glutathione reductase) and decreased oxidants (thiobarbituric acid reactive substances). Furthermore, combination therapy significantly increased the Mini Mental State Examination score, when compared to dexamethasone monotherapy. CONCLUSION: Administration of a combination of vinpocetine and dexamethasone may enhance the anti-inflammatory and anti-oxidative effects when compared to dexamethasone monotherapy, which leads to alleviated cognitive impairment in NPC patients with radiation injury.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Cognitive Dysfunction/drug therapy , Dexamethasone/pharmacology , Nasopharyngeal Carcinoma/radiotherapy , Nasopharyngeal Neoplasms/radiotherapy , Radiation Injuries/drug therapy , Vinca Alkaloids/pharmacology , Adult , Anti-Inflammatory Agents/therapeutic use , Antioxidants/metabolism , Cognition/drug effects , Cognitive Dysfunction/etiology , Cytokines/blood , Cytokines/drug effects , Dexamethasone/therapeutic use , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Inflammation/blood , Male , Mental Status and Dementia Tests , Middle Aged , Oxidants/metabolism , Oxidative Stress/drug effects , Radiation Injuries/complications , Random Allocation , Toll-Like Receptors/blood , Toll-Like Receptors/drug effects , Vinca Alkaloids/therapeutic useABSTRACT
We investigated Toll-like receptor (TLR)-3/-7/-8/-9 and interferon (IFN)-α/ß/γ mRNA expression in whole blood and serum IFN-α/ß/γ levels in patients with mixed connective tissue disease (MCTD), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) and in healthy subjects to assess the association between the TLR-IFN expression and severity of and susceptibility to diseases, and identify potential biomarkers. Expression of the IFN-γ, TLR-3 and TLR-8 was detected only in SLE patients. TLR-7, IFN-α and IFN-ß expression was highest in SLE, while TLR-9 expression was highest in SSc patients. In SLE and MCTD patients a strong correlation was observed between TLR-7 and IFN-α expression and IFN-ß and IFN-α expression. In MCTD patients, negative correlation between IFN-α and TLR-9 and TLR-7 and TLR-9 was revealed. TLR-9 expression in anti-U1-70k-negative, anti-C negative and anti-SmB-negative MCTD patients was higher than in MCTD-positive patients. We observed negative correlations between serum IFN-α levels and TLR-7 expression and C3 and C4 levels in SLE patients. In SLE patients we observed that with increased IFN-γ, TLR-3 and TLR-8 expression increased the value of C3 and C4. Our results confirmed that the endosomal TLR-IFN pathway seems to be more important in SLE than in MCTD or SSc, and that IFN-α and IFN-ß may be possible biomarkers for SLE.
Subject(s)
Gene Expression Profiling/methods , Interferons/genetics , Lupus Erythematosus, Systemic/genetics , Mixed Connective Tissue Disease/genetics , Scleroderma, Systemic/genetics , Toll-Like Receptors/genetics , Adult , Aged , Aged, 80 and over , Endosomes/genetics , Endosomes/metabolism , Female , Humans , Interferon-alpha/blood , Interferon-alpha/genetics , Interferon-alpha/metabolism , Interferon-beta/blood , Interferon-beta/genetics , Interferon-beta/metabolism , Interferon-gamma/blood , Interferon-gamma/genetics , Interferon-gamma/metabolism , Interferons/blood , Interferons/metabolism , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/metabolism , Male , Middle Aged , Mixed Connective Tissue Disease/blood , Mixed Connective Tissue Disease/metabolism , Scleroderma, Systemic/blood , Scleroderma, Systemic/metabolism , Toll-Like Receptor 3/blood , Toll-Like Receptor 3/genetics , Toll-Like Receptor 3/metabolism , Toll-Like Receptor 7/blood , Toll-Like Receptor 7/genetics , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 8/blood , Toll-Like Receptor 8/genetics , Toll-Like Receptor 8/metabolism , Toll-Like Receptor 9/blood , Toll-Like Receptor 9/genetics , Toll-Like Receptor 9/metabolism , Toll-Like Receptors/blood , Toll-Like Receptors/metabolism , Young AdultABSTRACT
The DNA binding protein AT-rich interacting domain 3a (ARID3a)2 is expressed in healthy human hematopoietic cord blood progenitors where its modulation influences myeloid versus B lineage development. ARID3a is also variably expressed in subsets of adult peripheral blood hematopoietic progenitors where the consequences of ARID3a expression are unknown. In B lymphocytes, Toll-like receptor (TLR)3 signaling induces ARID3a expression in association with Type I interferon inflammatory cytokines. We hypothesized that TLR ligand stimulation of peripheral blood hematopoietic progenitors would induce ARID3a expression resulting in interferon production, and potentially influencing lineage decisions. Our data revealed that the TLR9 agonist CpG induces ARID3a expression with interferon alpha synthesis in human hematopoietic progenitors. However, ARID3a expression was not associated with increased B lineage development. These results demonstrate the need for further experiments to better define how pathogen-associated responses influence hematopoiesis.
Subject(s)
DNA-Binding Proteins/biosynthesis , Hematopoietic Stem Cells/metabolism , Interferon-alpha/biosynthesis , Toll-Like Receptors/blood , Transcription Factors/biosynthesis , Adult , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , CpG Islands , Cytokines/metabolism , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/blood , Female , Flow Cytometry/methods , Gene Expression , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Humans , Interferon-alpha/genetics , Interferon-alpha/immunology , Ligands , Middle Aged , Signal Transduction , Transcription Factors/antagonists & inhibitors , Transcription Factors/bloodABSTRACT
OBJECTIVES: The analysis of annotated transcripts from genome-wide expression studies may help to understand the pathogenesis of complex diseases, such as systemic sclerosis (SSc). We performed a whole blood (WB) transcriptome analysis on RNA collected in the context of the European PRECISESADS project, aiming at characterising the pathways that differentiate SSc from controls and that are reproducible in geographically diverse populations. METHODS: Samples from 162 patients and 252 controls were collected in RNA stabilisers. Cases and controls were divided into a discovery (n=79+163; Southern Europe) and validation cohort (n=83+89; Central-Western Europe). RNA sequencing was performed by an Illumina assay. Functional annotations of Reactome pathways were performed with the Functional Analysis of Individual Microarray Expression (FAIME) algorithm. In parallel, immunophenotyping of 28 circulating cell populations was performed. We tested the presence of differentially expressed genes/pathways and the correlation between absolute cell counts and RNA transcripts/FAIME scores in regression models. Results significant in both populations were considered as replicated. RESULTS: Overall, 15 224 genes and 1277 functional pathways were available; of these, 99 and 225 were significant in both sets. Among replicated pathways, we found a deregulation in type-I interferon, Toll-like receptor cascade, tumour suppressor p53 protein function, platelet degranulation and activation. RNA transcripts or FAIME scores were jointly correlated with cell subtypes with strong geographical differences; neutrophils were the major determinant of gene expression in SSc-WB samples. CONCLUSIONS: We discovered a set of differentially expressed genes/pathways validated in two independent sets of patients with SSc, highlighting a number of deregulated processes that have relevance for the pathogenesis of autoimmunity and SSc.
Subject(s)
Autoimmunity/genetics , Scleroderma, Systemic/genetics , Signal Transduction/genetics , Transcriptome/genetics , Adult , Aged , Cohort Studies , Europe , Female , Gene Expression Profiling , Genome-Wide Association Study , Humans , Immunophenotyping , Interferon Type I/blood , Male , Microarray Analysis , Middle Aged , Sequence Analysis, RNA , Toll-Like Receptors/bloodABSTRACT
OBJECTIVE: Thrombocytopenia is associated with many viral infections suggesting virions interact with and affect platelets. Consistently, viral particles are seen inside platelets, and platelet activation markers are detected in viremic patients. In this article, we sought mechanistic insights into these virion/platelet interactions by examining how platelets endocytose, traffic, and are activated by a model virion. Approach and Results: Using fluorescently tagged HIV-1 pseudovirions, 3-dimensional structured illumination microscopy, and transgenic mouse models, we probed the interactions between platelets and virions. Mouse platelets used known endocytic machinery, that is, dynamin, VAMP (vesicle-associated membrane protein)-3, and Arf6 (ADP-ribosylation factor 6), to take up and traffic HIV-1 pseudovirions. Endocytosed HIV-1 pseudovirions trafficked through early (Rab4+) and late endosomes (Rab7+), and then to an LC3+ (microtubule-associated protein 1A/1B-light chain 3) compartment. Incubation with virions induced IRAK4 (interleukin 1 receptor-associated kinase 4), Akt (protein kinase B), and IKK (IκB kinase) activation, granule secretion, and platelet-leukocyte aggregate formation. This activation required TLRs (Toll-like receptors) and MyD88 (myeloid differentiation primary response protein 88) but was less extensive and slower than activation with thrombin. In vivo, HIV-1 pseudovirions injection led to virion uptake and platelet activation, as measured by IKK activation, platelet-leukocyte aggregate formation, and mild thrombocytopenia. All were decreased in VAMP-3-/- and, megakaryocyte/platelet-specific, Arf6-/- mice. Similar platelet activation profiles (increased platelet-leukocyte aggregates, plasma platelet factor 4, and phospho-IκBα) were detected in newly diagnosed and antiretroviral therapy-controlled HIV-1+ patients. CONCLUSIONS: Collectively, our data provide mechanistic insights into the cell biology of how platelets endocytose and process virions. We propose a mechanism by which platelets sample the circulation and respond to potential pathogens that they take up.
Subject(s)
Blood Platelets/metabolism , Endocytosis , HIV Infections/blood , HIV-1/pathogenicity , Platelet Activation , Thrombocytopenia/blood , Toll-Like Receptors/blood , Virion , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/blood , ADP-Ribosylation Factors/genetics , Animals , Anti-Retroviral Agents/therapeutic use , Blood Platelets/virology , Cell Aggregation , Cells, Cultured , HIV Infections/diagnosis , HIV Infections/drug therapy , HIV Infections/virology , Humans , I-kappa B Kinase/blood , I-kappa B Kinase/genetics , Leukocytes/metabolism , Leukocytes/virology , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/blood , Myeloid Differentiation Factor 88/genetics , Platelet Factor 4/blood , Platelet Factor 4/genetics , Thrombocytopenia/diagnosis , Thrombocytopenia/virology , Toll-Like Receptors/deficiency , Toll-Like Receptors/genetics , Vesicle-Associated Membrane Protein 3/blood , Vesicle-Associated Membrane Protein 3/geneticsABSTRACT
DESIGN: Since intestinal immunity and the microbiome are disrupted in HIV disease, we studied the abundance of innate immune sensors, Toll-like receptors (TLRs), in the mucosa of participants with viremia, prior to antiretroviral therapy (ART), immune success (>500 CD4 T cells/µl after 2 years of ART; suppressed viremia), and immune failure (<350 CD4 T cells/µl after 2 years of ART; suppressed viremia). We hypothesized that disruption of intestinal TLR abundance and location provides a mechanism behind persistent inflammation. METHODS: Immunofluorescence for TLR3, TLR4, and TLR9 on paraffin embedded biopsies from uninfected, viremic, immune success, and immune failure colons was imaged by deconvolution microscopy and quantified with MetaMorph software. Plasma levels of C-reactive protein, IL-6, and intestinal fatty-acid binding protein (I-FABP) were correlated with TLR expression. RESULTS: Viremic participants have significantly higher levels of TLR3 and TLR9 on surface epithelium and in crypts when compared with uninfected controls. TLR3 is further elevated in immune failure and immune success. TLR9 abundance remains elevated in immune failure and is normalized in immune success. TLR9 expression in the crypt and lamina propria positively associates with C-reactive protein and IL-6 and negatively with I-FABP. TLR4 is significantly lower on surface epithelium and higher in crypts in viremic. Its expression in the lamina propria positively correlates with IL-6 and negatively correlates with I-FABP. CONCLUSION: Mucosal TLR imbalance and deregulation, and the resulting mucosal TLR desensitization and hypervigilance, remain after suppressive ART, in the presence or absence of T-cell recovery, likely contributing to chronic systemic inflammation.
Subject(s)
Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active/methods , HIV Infections/drug therapy , HIV Infections/metabolism , Intestinal Mucosa/immunology , Mucous Membrane/immunology , Toll-Like Receptors/blood , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Epithelium , HIV Infections/immunology , Humans , Toll-Like Receptor 7/blood , Toll-Like Receptor 9 , Toll-Like Receptors/metabolism , Viral Load , Viremia/immunologyABSTRACT
BACKGROUND: Preterm infants are at high risk of infection and have distinct pathogen recognition responses. Suggested mechanisms include soluble mediators that enhance cellular levels of cAMP. The aim of this study was to assess the relationship between blood cAMP concentrations and TLR-mediated cytokine production in infants during the first month of life. METHODS: Cord and serial peripheral blood samples (days of life 1-28) were obtained from a cohort of very preterm (<30 weeks' gestational age) and term human infants. Whole-blood concentrations of cAMP and FSL-1 and LPS in vitro stimulated cytokine concentrations were measured by ELISA and multiplex bead assay. RESULTS: cAMP concentrations were higher in cord than in peripheral blood, higher in cord blood of female preterm infants, and lower at Days 1 and 7 in infants exposed to chorioamnionitis, even after adjusting for leukocyte counts. TLR2 and TLR4-mediated TNF-α, IL-1ß, IL-6, IL-12p70, and IL-10 production in vitro increased over the first month of life in preterm infants and were positively correlated with leukocyte-adjusted cAMP levels and reduced by exposure to chorioamnionitis. CONCLUSIONS: The ontogeny of blood cAMP concentrations and associations with chorioamnionitis and TLR-mediated production of cytokines suggest that this secondary messenger helps shape distinct neonatal pathogen responses in early life.
Subject(s)
Chorioamnionitis/blood , Cyclic AMP/blood , Cytokines/blood , Fetal Blood/metabolism , Infant, Premature/blood , Inflammation Mediators/blood , Leukocytes/metabolism , Toll-Like Receptors/blood , Cells, Cultured , Chorioamnionitis/immunology , Diglycerides/pharmacology , Female , Fetal Blood/immunology , Gestational Age , Humans , Infant, Newborn , Infant, Premature/immunology , Leukocytes/drug effects , Leukocytes/immunology , Lipopolysaccharides/pharmacology , Longitudinal Studies , Male , Oligopeptides/pharmacology , Pregnancy , Prospective Studies , Toll-Like Receptors/agonistsABSTRACT
TLRs are thought to play a role in the pathophysiology of such dermatological diseases as leprosy, acne and psoriasis. The study included 20 patients with plaque psoriasis, as well as 20 healthy age- and gender-matched control subjects. Real-time polymerase chain reaction evaluation was made of the messenger RNA expression of TLRs 1-10 in lesional tissue and peripheral blood mononuclear cell samples in psoriasis patients. TLR 3, 5, 6, 7, 9 and 10 lesional tissue mRNA expressions were increased significantly when compared to the expression levels in the PBMCs of the same patients (pâ¯=â¯0.0082, pâ¯=â¯0.0176, pâ¯=â¯0.0239, pâ¯=â¯0.0261, pâ¯=â¯0.0223, pâ¯=â¯0.0206). A comparison of the TLR expression in the PBMCs of healthy subjects and the PBMCs of patients with psoriasis showed a significant increase in the TLR 1, 8 and 10 mRNA expressions in the patient group (pâ¯<â¯0.0001, pâ¯<â¯0.0001, pâ¯=â¯0.0035). The TLR 5 mRNA expression was significantly higher in the control group than in the patient group (pâ¯=â¯0.0037). To the best of our knowledge, this is the first study in literature to evaluate mRNA TLR expression levels in the lesional tissue and PBMCs of patients with psoriasis.
Subject(s)
Psoriasis/metabolism , Toll-Like Receptors/metabolism , Adult , Female , Gene Expression , Humans , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , Psoriasis/blood , Psoriasis/genetics , Toll-Like Receptor 1/blood , Toll-Like Receptor 1/genetics , Toll-Like Receptor 10/blood , Toll-Like Receptor 10/genetics , Toll-Like Receptor 8/blood , Toll-Like Receptor 8/genetics , Toll-Like Receptors/blood , Toll-Like Receptors/geneticsABSTRACT
BACKGROUND: Innate immunity plays a crucial role in host-virus interactions and greatly influences viral replication including HBV infection. However, few studies have investigated the possible antiviral immune roles played by TLRs, RIG-I, and long no-coding RNA NEAT1 in chronic HBV infection (CHB) patients in clinical samples and their relationships among immune responses. In this study, we sought to investigate the mRNA expression levels of TLR1-10, RIG-I, and NEAT1 expression in HBeAg-positive CHB treatment-naïve patients with the active phase. METHODS: The expression levels of TLR1-10, RIG-I, and NEAT1 of CHB patients with the active phase and healthy controls were measured by qPCR. Serum HBV DNA and routine liver biochemistry including ALT, etc were also measured to evaluate the impaired physiological function of the liver affected by CHB. RESULTS: The expression levels of TLR1 and TLR6 in CHB with active phase were remarkably lower than that in healthy controls. The levels of TLR3 in CHB patients with active phase were remarkably higher than that in healthy controls. The total NEAT1 expression was abnormally decreased in CHB patients as compared with healthy controls. The levels of RIG-I were significantly decreased in CHB patients in the active phase when compared to healthy controls. The expression of TLR6 and RIG-I was closely correlated with NEAT1 expression. TLR6 level was positively correlated with RIG-I level. CONCLUSION: Chronic HBV infection can alter the innate immune response by downregulating functional expression of TLR1, TLR6, NEAT1.
Subject(s)
DEAD Box Protein 58/blood , Hepatitis B e Antigens/blood , Hepatitis B, Chronic/etiology , RNA, Long Noncoding/blood , Toll-Like Receptors/blood , Adult , Biomarkers/blood , Case-Control Studies , DEAD Box Protein 58/genetics , Down-Regulation/genetics , Female , Gene Expression Regulation , Humans , Immunity, Innate/genetics , Male , Receptors, Immunologic , Toll-Like Receptors/geneticsABSTRACT
Increasing evidence suggests that in addition to neurochemical abnormalities, various immunological alterations are related to the pathogenesis of schizophrenia. Toll-like receptors (TLRs) actively mediate immune/inflammatory processes and play a pivotal role in damage/danger recognizing. Therefore, the aim of this study was to compare the expression of TLRs in peripheral blood mononuclear cells (PBMCs) in schizophrenic patients with those of healthy subjects. It also measures the metabolic status of the study subjects. Twenty-seven adult European Caucasian patients with paranoid schizophrenia and twenty-nine healthy volunteers were included in this prospective study. qRT-PCR assessed TLR mRNA expression levels. Body composition was measured using two methods: bioimpedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA). The TLR1, TLR2, TLR4, TLR6, and TLR9 expression were down-regulated, in opposite to TLR3 and TLR7 which manifested higher expression in patients with schizophrenia. TLR5 and TLR8 mRNAs did not differ between groups. TLR mRNA expression was highly correlated. Decreased TLR expression may protect against excessive cell stimulation via exogenous and/or endogenous ligands, and may be recognized as a counterbalancing mechanism limiting the excessive development of inflammation.
Subject(s)
Leukocytes, Mononuclear/metabolism , Schizophrenia/blood , Toll-Like Receptors/blood , Adolescent , Adult , Biomarkers/blood , Cross-Sectional Studies , Female , Gene Expression , Humans , Male , Middle Aged , Prospective Studies , RNA, Messenger/biosynthesis , RNA, Messenger/blood , RNA, Messenger/genetics , Schizophrenia/diagnosis , Schizophrenia/genetics , Toll-Like Receptors/biosynthesis , Toll-Like Receptors/genetics , Young AdultABSTRACT
BACKGROUND: The pathogenesis of Parkinson's disease (PD) is complex; it includes mitochondrial dysfunction, oxidative stress, and neuroinflammation. Notably, Toll-like receptors (TLRs) may activate inflammatory or anti-inflammatory responses in Parkinson's disease. Vinpocetine has been tested as an anti-inflammatory in both animal and in vitro research. Thus, it is important to test whether the anti-inflammatory properties of vinpocetine may have a protective effect in PD patients. METHODS: Eighty-nine Parkinson's disease patients and 42 healthy controls were recruited for this study. All patients were randomly assigned to either the traditional therapy group (T PD group, n = 46) or the vinpocetine group (V PD group, n = 43), in a blinded manner. Both treatments were administered for 14 days. RESULTS: Administration of vinpocetine reduced mRNA levels of TLR2/4, as well as protein levels of the downstream signalling molecules, MyD88 and NF-κB; moreover, it lowered the expression levels of serum inflammatory cytokines, TNF-α and MCP-1. Notably, vinpocetine increased TLR3 mRNA levels, as well as protein levels of the downstream signalling molecules TRIF-ß and IRF-3, and serum levels of the anti-inflammatory cytokines IL-10 and IL-8. Furthermore, vinpocetine produced a robust increase in the Mini Mental State Examination score, compared to that achieved by using levodopa therapy. CONCLUSION: Vinpocetine treatment may exhibit anti-inflammatory activity and alleviate cognitive impairment.
Subject(s)
Neuroprotective Agents/therapeutic use , Parkinson Disease/blood , Parkinson Disease/drug therapy , Toll-Like Receptors/blood , Vinca Alkaloids/therapeutic use , Aged , Biomarkers/blood , Case-Control Studies , Cohort Studies , Double-Blind Method , Female , Humans , Male , Middle Aged , Neuroprotective Agents/pharmacology , Random Allocation , Toll-Like Receptors/antagonists & inhibitors , Vinca Alkaloids/pharmacologyABSTRACT
BACKGROUND: Surgical insult and trauma have been shown to cause dysregulation of the immune and inflammatory responses. Interaction of damage-associated molecular patterns (DAMPs) with toll-like receptors (TLRs) initiates innate immune response and systemic inflammatory responses. Given that surgical patients produce high levels of circulating damage-associated molecular patterns, we hypothesized that plasma-activated TLR activity would be correlated to injury status and could be used to predict pathological conditions involving tissue injury. METHODS: An observational study was performed using samples from a single-institution prospective tissue and data repository from a Level-1 trauma center. In vitro TLR 2, 3, 4, and 9 activation was determined in a TLR reporter assay after isolation of plasma from peripheral blood. We determined correlations between plasma-activated TLR activity and clinical course measures of severity. RESULTS: Eighteen patients were enrolled (median Injury Severity Score 15 [interquartile range 10, 23.5]). Trauma resulted in significant elevation in circulation high mobility group box 1 as well as increase of plasma-activated TLR activation (2.8-5.4-fold) compared to healthy controls. There was no correlation between circulating high mobility group box 1 and trauma morbidity; however, the plasma-activated TLR activity was correlated with acute physiology and chronic health evaluation II scores (R square = 0.24-0.38, P < 0.05). Patients who received blood products demonstrated significant increases in the levels of plasma-activated TLRs 2, 3, 4, and 9 and had a trend toward developing systemic inflammatory response syndrome. CONCLUSIONS: Further studies examining TLR modulation and signaling in surgical patients may assist in predictive risk modeling and reduction in morbidity and mortality.
Subject(s)
Alarmins/metabolism , Toll-Like Receptors/blood , Wounds and Injuries/blood , Adult , Biomarkers/blood , Case-Control Studies , Cell Line, Tumor , Female , HMGB1 Protein/blood , Humans , Male , Middle AgedABSTRACT
BACKGROUND: Cryptococcal meningitis (CM) is a significant source of mortality, the pathogenesis of which has not been fully understood, especially in non-HIV infected populations. We aimed to explore the potential genetic influence of Toll-like receptor (TLR) on non-HIV CM. METHODS: This observational cohort study was done in two stages: a discovery stage and a validation stage. A case-control genetic association study was conducted between 159 non-HIV CM patients and 468 healthy controls. TLR SNPs significantly related to susceptibility went further validation in a second cohort of 583 subjects from a certain district. Associations among TLR SNPs, cerebrospinal fluid (CSF) cytokine concentrations, and clinical severity were explored in a third cohort of 99 previously untreated non-HIV CM patients. Logistic regression model was used to determine the independent predictors for disease severity. FINDINGS: In the discovery stage, eight TLR SNPs exhibited significant genetic susceptibility to non-HIV CM, one of which was validated in a population validation of HIV-infected cases while none survived in non-HIV cases. CSF cytokine detections showed that 18 cytokines were significantly over-expressed in severely ill patients. Two of the 8 SNPs (rs5743604 and rs3804099) were also significantly associated with disease severity. Specifically, the rs3804099 C/T genotype was further found to be correlated to 12 of the 18 up-regulated cytokines in severe patients. In addition, high levels of interleukin (IL)-10 in CSF (OR 2·97, 95% CI 1·49-5·90; pâ¯=â¯0·002) was suggested as an independent predictor for severity after adjusted for possible confounders. INTERPRETATION: TLR participates in both the occurrence and the pathogenesis of non-HIV CM. The in situ immune responses of CM were under genetic influence of TLR and contributed to disease severity. FUND: National Natural Science Foundation of China and National Key Basic Research Program of China (973 Program).
Subject(s)
Meningitis, Cryptococcal/genetics , Polymorphism, Single Nucleotide , Toll-Like Receptors/genetics , Adolescent , Adult , Aged , Cohort Studies , Female , HIV Infections , Humans , Interleukin-10/blood , Male , Meningitis, Cryptococcal/blood , Meningitis, Cryptococcal/epidemiology , Middle Aged , Toll-Like Receptors/bloodABSTRACT
BACKGROUND: Alterations in gene expression in peripheral blood cells play a curtail role in the presence and extent of coronary artery disease (CAD), but its severity reflected by gene expression alterations in peripheral blood cells is still unknown in Xinjiang population in China. METHODS: Global gene expression profiling in peripheral blood was used to explore differentially expressed genes in coronary artery stenosis patients. RNA was extracted from peripheral blood of 9 controls without coronary stenosis and 21 cases with angiographically CAD. The extent of CAD severity was categorized angiographically as no CAD, mild CAD (20 to 50% luminal diameter stenosis [LDS]), moderate CAD (50 to 75% LDS) and severe CAD (≥75% LDS). Differentially expressed genes related with CAD severity from peripheral blood cells were screened by linear mixed effects analysis using the lme4 package in R. Then the differentially expressed genes that gradually up-regulated or down-regulated were enriched by Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. RESULTS: The most significantly enrichments were toll-like receptor signaling pathway, immune responses, translational processes, cellular growth, inflammation and metabolic processes. Combined with NCBI-GeneRIF and PubMed analysis, we focused on the 12 genes associated with toll-like receptor signaling pathway in the extent of coronary artery stenosis patients. Receiver operating characteristic (ROC) analysis of 12 genes associated with toll-receptor signaling pathway in the 236 CAD patients from GEO database demonstrated that 12 genes expression could predict severe CAD with an area under the curve of 0.67, sensitivity of 77.65% and specificity of 51.52%. CONCLUSION: These results suggest that 12 genes associated with toll-like receptor signaling pathway in peripheral-blood cells reflect the presence and extent of CAD severity in Xinjiang population in China.
Subject(s)
Coronary Artery Disease/genetics , Coronary Stenosis/genetics , Leukocytes, Mononuclear/metabolism , Lipids/blood , Toll-Like Receptors/genetics , Adult , Biomarkers/blood , Case-Control Studies , China , Coronary Angiography , Coronary Artery Disease/blood , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/pathology , Coronary Stenosis/blood , Coronary Stenosis/diagnostic imaging , Coronary Stenosis/pathology , Female , Gene Expression Profiling , Gene Expression Regulation , Gene Ontology , Humans , Interleukin-1 Receptor-Associated Kinases/blood , Interleukin-1 Receptor-Associated Kinases/genetics , Leukocytes, Mononuclear/pathology , Male , Microarray Analysis , Middle Aged , Mitogen-Activated Protein Kinases/blood , Mitogen-Activated Protein Kinases/genetics , Molecular Sequence Annotation , Receptors, Interleukin-1/blood , Receptors, Interleukin-1/genetics , Sensitivity and Specificity , Severity of Illness Index , Signal Transduction , Toll-Like Receptors/bloodSubject(s)
Apolipoprotein E3/genetics , Apolipoprotein E4/genetics , Diet, Western , Immunity, Innate , Toll-Like Receptors/blood , Acute-Phase Proteins/metabolism , Alkaline Phosphatase/metabolism , Animals , Carrier Proteins/metabolism , Feces/chemistry , Female , Genotype , Humans , Lipopolysaccharide Receptors/metabolism , Liver/enzymology , Male , Membrane Glycoproteins/metabolism , MiceABSTRACT
Chronic low-grade inflammation is the hallmark of type 2 diabetes (T2D). Although in vitro and animal studies have shown that resveratrol exerts anti-inflammatory effects, clinical trials addressing these effects in patients with T2D are limited. Therefore, in the present study, we hypothesized that supplementation of resveratrol might improve inflammatory markers in patients with T2D in a randomized, double-blind, placebo-controlled clinical trial. A total of 45 T2D patients were supplemented with either of 800â¯mg/d resveratrol or placebo capsules for 8 weeks. Percentage of CD14+CD16+ monocytes, plasma levels of inflammatory cytokines (tumor necrosis factor α, interleukin [IL] 1ß, IL-6, and monocyte chemoattractant protein-1), the expression levels of genes involved in the inflammatory responses (toll-like receptor 2, toll-like receptor 4, and nuclear factor κB), lipopolysaccharide-stimulated cytokine (tumor necrosis factor α, IL-1ß, and IL-6) secretion from peripheral blood mononuclear cells, and metabolic and anthropometric parameters were assessed at both the baseline level and the end of the study. Compared with the placebo group, we could not detect any significant difference in the percentage of CD14+CD16+ monocytes, lipopolysaccharide-induced cytokine secretion, plasma levels of inflammatory cytokines, and the expression of inflammatory genes in resveratrol group. Moreover, we did not find any significant change in the metabolic and anthropometric parameters except for a significant reduction in fasting blood glucose and blood pressure. In conclusion, 8-week supplementation of resveratrol reduces blood glucose level in patients with T2D without improving their inflammatory markers.
Subject(s)
Blood Glucose/metabolism , Cytokines/blood , Diabetes Mellitus, Type 2/blood , Inflammation Mediators/blood , Inflammation/blood , Monocytes/metabolism , Resveratrol/pharmacology , Aged , Antioxidants/pharmacology , Biomarkers/blood , Chemokine CCL2/blood , Diabetes Mellitus, Type 2/complications , Dietary Supplements , Double-Blind Method , Female , Humans , Inflammation/etiology , Interleukins/blood , Lipopolysaccharide Receptors , Male , Middle Aged , NF-kappa B/blood , Plant Extracts/pharmacology , Receptors, IgG , Toll-Like Receptors/blood , Tumor Necrosis Factor-alpha/bloodABSTRACT
Riemerella anatipestifer (R. anatipestifer) is a Gram-negative bacterium that crosses the blood-brain barrier (BBB) and causes meningitis with neurological symptoms in infected ducks. A threshold level of bacteremia must be reached before the BBB can be breached. In this study, the bacterial burden and expression profiles of immune-related proteins in blood and brain tissue samples from R. anatipestifer-infected ducks were investigated. The data showed that R. anatipestifer could cross the BBB with low-level bacteremia of 7.5â¯×â¯102 CFU/ml in infected blood. Analysis of immune-related proteins revealed that IL-4, IL-17A, IL-17D, TLR3, TLR4, TLR7, and TGF-ß in blood, as well as IL-1ß, IL-2, IL-4, IL-17A, IL-17D, IL-17F, TLR3, TLR4, and TGF-ß in brain tissue were upregulated at an early stage in infection. The expression levels of Th1 and Th17-specific cytokines were significantly higher than those of Th2-specific cytokines, which indicated that mainly Th1 and Th17 immune responses were induced during R. anatipestifer infection.